UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade

Medical sciences (Basel), 2024-03, Vol.12 (1), p.15

2024

Volltextzugriff (PDF)

Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer

NPJ breast cancer, 2024-04, Vol.10 (1), p.26-26, Article 26

2024

Volltextzugriff (PDF)

Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade

Breast cancer research and treatment, 2024-06, Vol.205 (3), p.579-587

2024

Volltextzugriff (PDF)

Tumor subtypes and survival in male breast cancer

Breast cancer research and treatment, 2021-08, Vol.188 (3), p.695-702

2021

Volltextzugriff (PDF)

Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer

Cancer, 2022-11, Vol.128 (21), p.3796-3803

2022

Volltextzugriff (PDF)

Survival in male breast cancer over the past 3 decades

JNCI : Journal of the National Cancer Institute, 2023-04, Vol.115 (4), p.421-428

2023

Volltextzugriff (PDF)

Estimating mortality in women with triple-negative breast cancer: The ‘ESTIMATE triple-negative’ tool

European journal of cancer (1990), 2023-08, Vol.189, p.112930-112930, Article 112930

2023

Volltextzugriff (PDF)

Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool

European journal of cancer (1990), 2022-09, Vol.173, p.20-29

2022

Volltextzugriff (PDF)

Factors associated with late risks of breast cancer-specific mortality in the SEER registry

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.203-212

2021

Volltextzugriff (PDF)

Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry

Breast cancer research and treatment, 2021-06, Vol.187 (3), p.843-852

2021

Volltextzugriff (PDF)

Prognostic Significance of Tumor Subtypes in Women With Breast Cancer According to Stage: A Population-based Study

American journal of clinical oncology, 2019-07, Vol.42 (7), p.588-595

2019

Volltextzugriff (PDF)

Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study

American journal of clinical oncology, 2019-02, Vol.42 (2), p.215-220

2019

Volltextzugriff (PDF)

Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.305-305

2021

Volltextzugriff (PDF)

Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

JAMA oncology, 2024-04, Vol.10 (4), p.508

2024

Volltextzugriff (PDF)

Expression of ERCC1 and TUBB3 in Locally Advanced Cervical Squamous Cell Cancer and its Correlation with Different Therapeutic Regimens

The International journal of biological markers, 2015-07, Vol.30 (3), p.301-314

2015

Volltextzugriff (PDF)

Role of Difucosylated Lewis Y Antigen in Outcome of Locally Advanced Cervical Squamous Cell Carcinoma Treated with Cisplatin Regimen

The International journal of biological markers, 2016-07, Vol.31 (3), p.300-308

2016

Volltextzugriff (PDF)

Correction to: Factors associated with late risks of breast cancerâspecific mortality in the SEER registry

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.305

2021

Volltextzugriff (PDF)

Abstract PS6-13: Population-based tool to estimate residual risks of breast cancer specific mortality (BCSM) and non-BCSM

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-13-PS6-13

2021

Volltextzugriff (PDF)

Abstract P2-10-01: Estimating risk of breast cancer-specific mortality (BCSM) and non-BCSM in patients with triple-negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-10-01

2022

Volltextzugriff (PDF)

Abstract P5-06-13: Factors associated with twenty-year (y) risks of breast cancer-specific mortality (BCSM) for locally-advanced breast cancer (LABC) in the surveillance, epidemiology, and end results (SEER) registry

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-06-13

2020

Volltextzugriff (PDF)

Abstract PD7-05: Survival of patients with brain metastases at initial breast cancer diagnosis over the last decade

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD7-05-PD7-05

2023

Volltextzugriff (PDF)

Abstract PD6-08: PD6-08 Mortality risks over 20 years in men with stage I-III hormone receptor-positive breast cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD6-08-PD6-08

2023

Volltextzugriff (PDF)

Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma

American journal of clinical oncology, 2003-10, Vol.26 (5), p.477-482

2003

Volltextzugriff (PDF)

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

Haematologica (Roma), 2014-10, Vol.99 (10), p.1632-1637

2014

Volltextzugriff (PDF)

1 – 25 von 1.531

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.323)
Mit Volltextzugriff
(1.297)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade

Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer

Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade

Tumor subtypes and survival in male breast cancer

Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer

Survival in male breast cancer over the past 3 decades

Estimating mortality in women with triple-negative breast cancer: The ‘ESTIMATE triple-negative’ tool

Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool

Factors associated with late risks of breast cancer-specific mortality in the SEER registry

Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry

Prognostic Significance of Tumor Subtypes in Women With Breast Cancer According to Stage: A Population-based Study

Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study

Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry

Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

Expression of ERCC1 and TUBB3 in Locally Advanced Cervical Squamous Cell Cancer and its Correlation with Different Therapeutic Regimens

Role of Difucosylated Lewis Y Antigen in Outcome of Locally Advanced Cervical Squamous Cell Carcinoma Treated with Cisplatin Regimen

Correction to: Factors associated with late risks of breast cancerâspecific mortality in the SEER registry

Abstract PS6-13: Population-based tool to estimate residual risks of breast cancer specific mortality (BCSM) and non-BCSM

Abstract P2-10-01: Estimating risk of breast cancer-specific mortality (BCSM) and non-BCSM in patients with triple-negative breast cancer

Abstract P5-06-13: Factors associated with twenty-year (y) risks of breast cancer-specific mortality (BCSM) for locally-advanced breast cancer (LABC) in the surveillance, epidemiology, and end results (SEER) registry

Abstract PD7-05: Survival of patients with brain metastases at initial breast cancer diagnosis over the last decade

Abstract PD6-08: PD6-08 Mortality risks over 20 years in men with stage I-III hormone receptor-positive breast cancer

Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction–Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial

Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

Suchergebnisse filtern